Eylea sales drove Regeneron Q4 results higher

Quote

anonymous

Guest
Regeneron Pharmaceuticals reported a 371% jump in earnings for the fourth quarter helped by higher product sales and an income tax benefit as well as management of costs and expenses.

Net product sales grew to $1.1 billion from $979 million last year, helped by higher sales from Eylea injection that administered into the eye to treat certain retinal diseases. Libtayo, which was approved by the FDA to treat a type of skin cancer, had net product sales in the United States of $15 million in the fourth quarter of 2018.

A visual representation of the company's earnings results, as well as guidance, could be overlooked at https://news.alphastreet.com/regeneron-pharmaceuticals-q4-2018-earnings-regn-stock/
 












Once Congress enacts the special provisional Medicare amendment for reimbursement of lower cost alternative drugs Eyela is toast.

When docs get paid an equivalent amount for injecting Avastin as they do for Eyela, this house of cards collapses on your heads.

Enjoy while you can. It’s over by 2020.
 






anonymous said:
Once Congress enacts the special provisional Medicare amendment for reimbursement of lower cost alternative drugs Eyela is toast.

When docs get paid an equivalent amount for injecting Avastin as they do for Eyela, this house of cards collapses on your heads.

Enjoy while you can. It’s over by 2020.
Click to expand...

Sure government always does what it says
 












anonymous said:
Got hit up by a recruiter. Why are there so many Elyea openings? Side effect issue, layoffs, biosimilars?
Click to expand...

Big Pharma and incompetent leadership -MS and MM think that mirrored counterparts makes sense to call on retina specialists in anticipation of a small new indication that they somehow see as a major breakthrough. These dopes are running people out of the company.
 
























Len is smitten with Len and George. Len finds the entire commercial organization repugnant and if he thought he could get away with lopping off the majority of the organization (Wall Street is really the only thing stopping him), that's exactly what he would do, he believes drugs sell themselves. This is why he moved the entire commercial organization out of Tarrytown to Sleepy Hollow. MM has maybe a smidge more influence with Len than you do.
 






anonymous said:
Len is smitten with Len and George. Len finds the entire commercial organization repugnant and if he thought he could get away with lopping off the majority of the organization (Wall Street is really the only thing stopping him), that's exactly what he would do, he believes drugs sell themselves. This is why he moved the entire commercial organization out of Tarrytown to Sleepy Hollow. MM has maybe a smidge more influence with Len than you do.
Click to expand...

Len is probably correct. Good drugs largely do sell on their own.
Marketing and sales at most pharma companies bloated and overpaid.
 






Some drugs do, but they are the exception. Launch uptake for Eylea had an awful lot to do with Retina Specialists trying to screw over Genentech/Roche for trying to restrict their access to Avastin.
 












Top Bottom
Back
Quote